Kewaunee Scientific (KEQU) EBITDA (2010 - 2026)

Kewaunee Scientific has reported EBITDA for 17 years, with the latest figure at $5.2 million in Q2 2026.

• On a quarterly basis, EBITDA fell 38.64% year-over-year to $5.2 million in Q2 2026; TTM through Apr 2026 was $16.7 million, a 5.88% decrease from a year earlier, with the FY2026 full-year figure at $16.7 million, down 5.88% from the prior year.
• EBITDA was $5.2 million for Q2 2026 at Kewaunee Scientific, up from $2.6 million in the prior quarter.
• The five-year high for EBITDA was $8.5 million in Q2 2025, with the low at -$868000.0 in Q1 2022.
• Average EBITDA over 5 years is $3.3 million, with a median of $3.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EBITDA sank 130.85% in 2022, then jumped 1061.62% in 2023.
• Over 5 years, EBITDA stood at $755000.0 in 2022, then jumped by 576.69% to $5.1 million in 2023, then declined by 13.21% to $4.4 million in 2024, then decreased by 7.37% to $4.1 million in 2025, then advanced by 27.0% to $5.2 million in 2026.
• The last three EBITDA figures came in at $5.2 million (Q2 2026), $2.6 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.